Incontinence, Urge
13
2
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Long-term Outcomes of Urethral and Uterosacral Ligament Plication
TReating Incontinence for Underlying Mental and Physical Health
Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder
Evaluation of the Efficacy of Transcutaneous Tibial Nerve Stimulation on Post-Stroke Overactive Bladder
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
Think Dry: Optimalisation of Diagnostic Process of Urinary Incontinence in Older People
To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence
The Effect of Incontinence Program Applied to Obese Elderly on Quality of Life, Coping and Loneliness
Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
T-DOC® 5 Fr Pediatric Clinical Investigation
T-DOC® NXT Clinical Investigation